Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction

Chang-Hui Liao1, Jun-Ting Cheng, Che-Ming Teng

  • 1Graduate Institute of Natural Products, College of Medicine Chang Gung University No 259 Wen-Hwa 1st Road, Kwei-Shan, Tao-Yuan county, 333 Taiwan, Republic of China. liaoch@mail.cgu.edu.tw

Insights

N-Formyl-Met-Leu-Phe (fMLP) stimulates neutrophils to release cathepsin G, activating platelets and forming neutrophil-platelet complexes. YC-1 inhibits this process via a cGMP-dependent pathway, reducing complex formation.

Area of Science:

  • Immunology
  • Hematology
  • Pharmacology

Background:

  • Neutrophil-platelet complex formation is induced by N-Formyl-Met-Leu-Phe (fMLP).
  • fMLP-stimulated neutrophils activate platelets, involving P-selectin.
  • Cathepsin G released from neutrophils activates platelets, contributing to complex formation.

Purpose of the Study:

  • To investigate the inhibitory effects of YC-1 on fMLP-induced neutrophil-platelet complex formation.
  • To elucidate the underlying mechanisms of YC-1's action, including its effect on cathepsin G release and P-selectin expression.
  • To evaluate YC-1's efficacy in whole blood models.

Main Methods:

  • Co-incubation of neutrophils and platelets with fMLP.
  • Assessment of intracellular calcium mobilization in platelets.
  • Inhibition studies using monoclonal antibody 9E1 (anti-P-selectin).
  • Evaluation of YC-1, ODQ (guanylate cyclase inhibitor), and KT5835 (protein kinase G inhibitor).
  • Measurement of cathepsin G release and P-selectin expression.
  • Experiments conducted in whole blood.

Main Results:

  • YC-1 inhibited fMLP-induced neutrophil-platelet complex formation in a concentration-dependent manner (IC50 = 15.3 µM).
  • YC-1 inhibited fMLP-induced cathepsin G release (IC50 = 6.2 µM) and cathepsin G-induced P-selectin expression on platelets (IC50 = 32.5 µM).
  • Inhibitory effects of YC-1 were partially reversed by ODQ and KT5835, suggesting a cGMP-dependent pathway.
  • YC-1 demonstrated efficacy in inhibiting neutrophil-platelet complex formation in whole blood (IC50 = 35.8 µM).

Conclusions:

  • YC-1 effectively inhibits fMLP-induced neutrophil-platelet complex formation.
  • The primary mechanism involves YC-1 inhibiting cathepsin G release from neutrophils via a cGMP-dependent pathway.
  • YC-1's inhibition of P-selectin expression on platelets may further contribute to its overall effect.
  • YC-1 shows potential as a therapeutic agent for conditions involving neutrophil-platelet activation.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...